Titre : | Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon (2012) |
Auteurs : | J. JERRY ; G. COLLINS ; D. STREEM |
Type de document : | Article : Périodique |
Dans : | Cleveland Clinic Journal of Medicine (Vol.79, n°4, April 2012) |
Article en page(s) : | 258-264 |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus mots-clés PHENOMENE EMERGENT ; DROGUES DE SYNTHESE ; INTOXICATION ; CANNABINOIDES ; EFFET SECONDAIRE ; MARCHE DE LA DROGUE ; SYMPTOME ; MEPHEDRONEThésaurus géographique ETATS-UNIS |
Résumé : |
Synthetic legal intoxicating drugs (SLIDs), such as those commonly contained in products sold over the counter as "bath salts" and "incense," have risen tremendously in popularity in the past few years. These drugs can have powerful adverse effects, including acute psychosis with delusions, hallucinations, and potentially dangerous, bizarre behavior.
KEY POINTS: • These products are sold under misleading names and deceptive labels to avoid regulation. Although several have recently been banned, many more are waiting to be brought to the market in a similar fashion. • "Incense" products often contain synthetic cannabinoids; scientific research into their potential long-term effects in humans has been very limited. • The potential for medical and psychiatric adverse events from synthetic cannabinoids may be heightened because of their full-agonist mechanism of action and because of the variable concentration and unregulated potency of these compounds in incense products. • Bath salt intoxication, when encountered in the emergency department, may present as a psychiatric disorder or as a range of medical problems including cardiovascular issues, seizures, and hyperthermia. |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 29 |
Affiliation : | Alcohol and Drug Recovery Center, Center for Behavioral Health, Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, OH 44195, USA |
Lien : | http://dx.doi.org/10.3949/ccjm.79a.11147 |
Accueil